SCHEMBL1305281

SCHEMBL1305281

COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)C2(CCC(c3ccccc3)(N(C)C)CC2)N1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 13/20 1.00
OGFRL1 Q5TC84 7/20 1.00
KMT2A Q03164 3/20 0.66
MEN1 O00255 1/20 0.66
OPRL1 P41146 7/20 0.57
KDM4E B2RXH2 3/20 0.50
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
GAA P10253 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
CYP2C19 P33261 1/20 0.50
OPRD1 P41143 2/20 0.48
OPRK1 P41145 2/20 0.48
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12045019 1.00 OPRM1 (1.00) OPRM1OGFRL1KMT2AMEN1OPRL1
Citric Acid SCHEMBL1303948 0.91 OPRM1 (0.82) OPRM1OGFRL1KMT2AMEN1OPRL1
SCHEMBL8324242 0.82 KMT2A (0.75) OPRM1OGFRL1KMT2AMEN1KDM4E
SCHEMBL682569 0.82 OPRM1 (1.00) OPRM1OGFRL1KMT2AOPRL1OPRD1
SCHEMBL1304263 0.81 OPRM1 (1.00) OPRM1OGFRL1KMT2AMEN1OPRL1
SCHEMBL682316 0.81 OPRM1 (1.00) OPRM1OGFRL1KMT2AMEN1OPRL1
SCHEMBL682318 0.78 OPRM1 (0.72) OPRM1OGFRL1KMT2AMEN1OPRL1
SCHEMBL6236178 0.78 OPRM1 (0.63) OPRM1OGFRL1KMT2AMEN1KDM4E
Citric Acid SCHEMBL1304000 0.77 OPRM1 (0.75) OPRM1OGFRL1KMT2AMEN1OPRL1
Citric Acid SCHEMBL1304968 0.76 OPRM1 (0.80) OPRM1OGFRL1KMT2AMEN1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4728645-B2 2011-07-20 JP claimed
EP-2233487-A1 Spirocyclic cyclohexane derivatives Grünenthal GmbH (DE) 2010-09-29 EP claimed
EP-2116544-A2 Spirocyclic cyclohexane derivatives Grünenthal GmbH (DE) 2009-11-11 EP claimed
EP-1560835-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-09-02 EP claimed
EP-2062898-A2 Spirocyclic cyclohexane derivatives Grünenthal GmbH (DE) 2009-05-27 EP claimed
EP-1560835-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2005-08-10 EP claimed
WO-2004043967-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2004-05-27 WO claimed
US-9862719-B2 Process or preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds GRUENENTHAL GMBH (DE) 2018-01-09 US disclosed
EP-2116544-B1 Spirocyclic cyclohexane derivatives GRUENENTHAL GMBH (DE) 2016-05-18 EP disclosed
EP-2233487-B1 Spirocyclic cyclohexane derivatives GRUENENTHAL GMBH (DE) 2016-05-18 EP disclosed
US-20150322080-A1 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds ADNEURIS THERAPEUTICS, INC. 2015-11-12 US disclosed
US-9120797-B2 Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds GRUENENTHAL GMBH (DE) 2015-09-01 US disclosed
EP-2062898-B1 Spirocyclic cyclohexane derivatives GRUENENTHAL GMBH (DE) 2013-10-02 EP disclosed
US-20090163716-A1 SPIROCYCLIC CYCLOHEXANE COMPOUNDS GRUENENTHAL GMBH (DE) 2009-06-25 US disclosed
US-20090156626-A1 Process for Preparing Spirocyclic Cyclohexane Compounds and Methods of Using Such Compounds GRENENTHAL GMBH (DE) 2009-06-18 US disclosed
US-7547707-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2009-06-16 US disclosed
EP-2062898-A2 Spirocyclic cyclohexane derivatives Grünenthal GmbH (DE) 2009-05-27 EP disclosed
US-20060004034-A1 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2006-01-05 US disclosed
EP-1560835-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2005-08-10 EP disclosed
WO-2004043967-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2004-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004034-A1 Spirocyclic cyclohexane compounds PKD1, PKD2, HSD17B7 OPRM1 1225/4885OGFRL1 1871/4885KMT2A 4227/4885
US-20150322080-A1 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds PKD1, VKORC1, PKD2 OPRM1 2030/4885OGFRL1 1903/4885KMT2A 4429/4885
US-20090163716-A1 SPIROCYCLIC CYCLOHEXANE COMPOUNDS PKD1, PKD2, HSD17B7 OPRM1 1225/4885OGFRL1 1871/4885KMT2A 4227/4885
US-20090156626-A1 Process for Preparing Spirocyclic Cyclohexane Compounds and Methods of Using Such Compounds PKD1, VKORC1, PKD2 OPRM1 1881/4885OGFRL1 1971/4885KMT2A 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.